Container1 (Container1)
Tizanidine Tablet
Product Images NDC 76420-866
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 76420-866). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Container2 (Container2)
This text contains information about various packages of Tizanidine tablets, USP 4 mg, in different quantities ranging from 30 to 1000 tablets. The tablets are manufactured by Enovachem for Norrtar Rx LLC. Each package is labeled with a specific NDC (National Drug Code) and LOT number. Instructions advise to keep the tablets out of reach of children and to store them at a specific temperature range. The text also mentions controlled room temperature conditions according to USP guidelines.*
Fig1 (Fig1)
This text provides information on Plasma Tzanidine Concentration at different doses and conditions, such as taking 4 mg Tzanidine Tablets with or without food as well as using Tzanidine Capsules in similar conditions. It also mentions the time frame (in hours) post-dosing for monitoring plasma concentration.*
Fig2 (Fig2)
This text provides data on the improvement in Ashworth Score after the administration of 16 mg of tizanidine compared to placebo at different hours post-dose.*
Fig3 (Fig3)
Improvement in Ashworth Score with Zanidine (mean dose 28.6 mg) studied from Week 3 to End of Maintenance Endpoint at Week 7 (Last Observation Carried Forward).*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
